Certain viruses, including SARS-CoV-2, are capable of causing brain cells to fuse, leading to malfunctions that eventually produce chronic neurological symptoms.
According to TauRx, a life sciences company based in Scotland, it is awaiting approval to become the first preventive treatment for this degenerative brain disease.